Sectors · Life sciences

Many have started with agents. Few are seeing value at scale.

Life sciences companies are rolling out agentic AI, but turning pilots into measurable results is the hard part. We build on clean master data and deliver agents into production.

The evidence

35%

of life sciences executives report significant progress in agentic AI, including enterprise-wide rollout or scaling.

Source: Deloitte, Jun 2026

13%

report measurable improvements from AI at scale.

Source: Deloitte, Jun 2026

Where agents pay back

  • Product, customer and supplier master-data stewardship.
  • Regulatory document assembly and checking.
  • Batch-record exception review.
  • Self-service analytics over clinical and commercial data.

In every case the agent prepares and a named person on your team decides.

How we start

Fixed-fee assessment, then a paid pilot

We rank your workflows by payback, build one governed agent on the best of them, and measure how often your reviewers agree with it before expanding.

How we govern AI →

Start with a fixed-fee assessment. Prove it with a paid pilot.

We find the two or three workflows where an agent pays back fastest, and tell you plainly where it won’t.